Next-generation molecular diagnostics from Wave 80LEARN MORE
Wave 80 Biosciences develops next-generation molecular diagnostics instruments and consumables for hepatitis C, hepatitis B, HIV/AIDS, and other human health conditions.
Distinguished by a novel one patient-one test usage model, best-in-class performance, and a superior value proposition, Wave 80’s pipeline products address unmet needs of diverse patient populations worldwide in the high-clinical-value molecular diagnostics segment of the clinical laboratory testing systems market.
Video: EOSCAPE and curbing the HIV epidemic
With more and more HIV patients in the U.S. and around the world receiving the antiretroviral drugs they need to live long, healthy lives, it’s now more important than ever to lower the rate of new infections – an estimated 2.7 million last year alone. Nucleic acid testing is a vital tool for reducing HIV transmission.See the EOSCAPE-HIV video